Please use this identifier to cite or link to this item:
Title: Respiratory function during infancy in survivors of the INNOVO trial.
Authors: Hoo, AF
Beardsmore, CS
Castle, RA
Ranganathan, SC
Tomlin, K
Field, D
Elbourne, D
Stocks, J
INNOVO Trial Collaborating Group
First Published: Feb-2009
Citation: PEDIATR PULMONOL, 2009, 44 (2), pp. 155-161
Abstract: Despite encouraging reports suggesting that inhaled nitric oxide (iNO) appear to improve outcome in hypoxemic term and near term infants by improving oxygenation and reducing need for ECMO, the long-term benefits of iNO remain unclear. This study aimed to compare lung function at approximately 1 year in infants who were and were not randomly allocated to iNO as part of their neonatal management for severe respiratory failure at birth. Furthermore, results were compared to lung function of healthy infants.
DOI Link: 10.1002/ppul.20967
eISSN: 1099-0496
Type: Journal Article
Appears in Collections:Published Articles, Dept. of Infection, Immunity and Inflammation

Files in This Item:
There are no files associated with this item.

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.